NCT00300872View on ClinicalTrials.gov

Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 6, 2019

Study Completion Date

August 6, 2019

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Continuous positive airway pressure (CPAP)

Continuous positive airway pressure (CPAP) - Horizon LT 8001 Continuous positive airway pressure (CPAP) device.

DEVICE

Sham Continuous positive airway pressure (CPAP)

Sham Continuous positive airway pressure (CPAP) - Continuous positive airway pressure (CPAP) units set to the lowest pressure (4 cm of water pressure) and 6 extra 4mm holes will be inserted in the collar of the main tubing at the end of the mask to allow air escape and to prevent carbon dioxide rebreathing.

Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00300872 - Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome | Biotech Hunter | Biotech Hunter